Strides Pharma Science Ltd (BOM:532531)
ā‚¹ 1579.2 -55.3 (-3.38%) Market Cap: 146.80 Bil Enterprise Value: 166.53 Bil PE Ratio: 62.72 PB Ratio: 6.40 GF Score: 68/100

Q4 2019 Strides Pharma Science Ltd Earnings Call Transcript

May 10, 2019 / 10:00AM GMT
Release Date Price: ā‚¹485.7 (+0.37%)
Operator

Ladies and gentlemen, good day, and welcome to the Strides Pharma Science Limited Q4 FY '19 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

I now hand over the conference to Mr. Abhishek Singhal to introduce the management. Thank you, and over to you, sir.

Abhishek Singhal
Macquarie Research - Former Associate Director

Very good afternoon, and thank you for joining us today for Strides earnings call for the fourth quarter FY '19. Today, we have with us Arun, Founder and Managing Director; and Badree, Executive Director, Finance, to share the highlights of the business and financials in the quarter.

I hope you have gone through our results release and the quarterly investor presentation, which have been uploaded on our website as well as the stock exchange. The transcript of this call will be available in a week's time on our company website.

Please note that today's discussion will be forward-looking in nature and must be viewed in relation to the risks pertaining to our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investorsā€™ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot